https://www.selleckchem.com/pr....oducts/golvatinib-e7
The clinical presentation of COVID-19 in patients admitted to hospital is heterogeneous. We aimed to determine whether clinical phenotypes of patients with COVID-19 can be derived from clinical data, to assess the reproducibility of these phenotypes and correlation with prognosis, and to derive and validate a simplified probabilistic model for phenotype assignment. Phenotype identification was not primarily intended as a predictive tool for mortality. In this study, we used data from two cohorts the COVID-19@Spain cohort, a ret
Aimer
Commentaire
Partagez
